A pair of studies show that Zepbound can help adults with obesity and overweight achieve sustained and meaningful weight loss ...

Patients with type 2 diabetes who switched to tirzepatide rather than escalating their dulaglutide dosage had greater weight ...

For adults struggling with weight, a weekly injection of tirzepatide offers real hope. Recent findings presented at the ...

Once-weekly treatment with tirzepatide can produce clinically meaningful and sustained weight loss for at least three ... and Drug Administration (FDA) (Zepbound) and in the EU in June 2024 ...

Two common GLP-1 medications that are approved by the Food and Drug Administration (FDA) specifically for weight loss are ...

Longest international trial on the effects of tirzepatide on weight in 700 adults with overweight or obesity and prediabetes reveals three distinct patterns of weight loss trajectories, with patients ...

Ro is a telehealth platform that connects you with licensed healthcare professionals, many of whom are in network with most major ... and tirzepatide (Zepbound) are approved for weight loss ...

You may know about tirzepatide, also known as Mounjaro or Zepbound, due to its popularity for those looking to lose weight or treat diabetes. Now, researchers have gotten it approved to treat sleep ...

Zepbound is a brand-name subcutaneous injection prescribed for weight loss and weight management ... It contains the active ingredient tirzepatide and comes in the form of a a solution that ...

In the long term, bariatric surgery is more cost-effective than new anti-obesity medications, research finds, triggering a ...

To what extent will health clinics go to keep selling in-demand weight-loss drugs now that the FDA has outlawed cheaper ...

Even more encouragingly, most people maintained the weight loss for the entire three-year study. “Our long-term analysis of tirzepatide ... U.S. FDA under the brand Zepbound in November 2023 ...